# Micafungin in Sodium Chloride

NDC: 0338-9051
Generic name: Micafungin in Sodium Chloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230929

FDA application: NDA216142

## Active ingredients

- MICAFUNGIN SODIUM: 50 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9051"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9051
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a95f901e-0ac4-4ec0-9720-9c6a066cd06c